About the Study

Each year in the United States, approximately 200,000 men are diagnosed with prostate cancer. Prostate cancer is the most common malignancy in men.

The goal of the study is to learn about how prostate cancer treatment affects patients’ quality of life. We believe this may help us discover how to improve the lives of prostate cancer patients.

Participants in NC ProCESS will play an important role in the fight against prostate cancer. Participation in this research study involves answering questions about prostate cancer in brief 30-60 minute telephone interviews. There will be five telephone interviews over a two year period.

Supported by

The study is funded by the Agency for Healthcare Research and Quality (AHRQ).

Research Team

NC ProCESS is led by Dr. Ronald Chen.

For more information:

Ronald Chen, MD, MPH
Principal Investigator
Assistant Professor
Cancer Prevention and Control

Paul Godley, MD, PhD
Co-Principal Investigator
Cancer Prevention and Control, Clinical Research Hematology/Oncology

Deborah Usinger
Project Manager
Cecil G. Sheps Center for Health Services Research
The University of North Carolina at Chapel Hill
101 East Weaver Street, Suite 220 CB# 7293
Chapel Hill, NC 27599

Kiayni Spearman
Research Assistant

Brittney Barbosa
Research Assistant